Stay updated on Pfizer Press Releases
Sign up to get notified when there's something new on the Pfizer Press Releases page.

Latest updates to the Pfizer Press Releases page
- Check2 days agoChange DetectedThe page now includes a significant addition regarding the survival outcomes of XTANDI® Plus Leuprolide for a specific cancer treatment, while a previous financial announcement about Pfizer's dividend has been removed.SummaryDifference10%
- Check9 days agoChange DetectedThe webpage has added a significant announcement regarding Pfizer's positive Phase 3 results for HYMPAVZI™ in treating Hemophilia A or B with inhibitors, while it has removed a previous update about Pfizer's vision for cancer care presented at the ASCO 2025 Annual Meeting.SummaryDifference12%
- Check16 days agoChange DetectedThe webpage now includes an invitation to a conference call and a declaration of a dividend by Pfizer, while it has removed updates on research and vaccine recommendations.SummaryDifference19%
- Check23 days agoNo Change Detected
- Check31 days agoNo Change Detected
- Check38 days agoChange DetectedThe webpage has been updated to include new research findings and corporate announcements from Pfizer, particularly regarding advancements in cancer treatment and vaccine recommendations. Notably, the deletion of previous announcements indicates a shift in focus towards more recent developments.SummaryDifference3%
- Check45 days agoChange DetectedThe webpage has removed several significant press releases related to Pfizer's financial results, licensing agreements, and vaccine approvals, while adding new press releases that highlight ongoing research and corporate updates.SummaryDifference86%
- Check52 days agoChange DetectedThe webpage has updated its content to reflect a new corporate licensing agreement involving Pfizer and 3SBio, while removing a previous announcement about a healthcare conference webcast.SummaryDifference10%
Stay in the know with updates to Pfizer Press Releases
Enter your email address, and we'll notify you when there's something new on the Pfizer Press Releases page.